OnKure Therapeutics appoints new vice president

BOULDER — Biopharmaceutical producer OnKure Inc. has appointed a new vice president of drug metabolism and pharmacokinetics and clinical pharmacology. Kevin Litwiler joins the cancer-therapy company with more than 30 years of experience in the pharmaceutical field.

Litwiler will work with OnKure Therapeutics on developing and refining the cancer therapies that the Boulder-based company has in its pipeline.

“Together with the OnKure team, I am confident in our ability to repeat past accomplishments and discover best-in-class oncology candidates that address significant unmet medical needs,” Litwiler said in a statement.

Litwiler previously held the title of executive director, clinical pharmacology global product development, oncology…